vaccinia virus recombinant Latest Research Papers

A double recombinant vaccinia virus VV-GMCSF-Lact, producing human GM-CSF and oncotoxic protein lactaptin, was constructed. Preclinical studies of VV-GMCSF-Lact as an antitumor drug for human solid tumors therapy were successfully completed. The drug is recommended for clinical trials.

Download Full-text

A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles

PLoS ONE ◽

10.1371/journal.pone.0075574 ◽

2013 ◽

Vol 8 (10) ◽

pp. e75574 ◽

Cited By ~ 3

Author(s):

Juana M. Sánchez-Puig ◽

María M. Lorenzo ◽

Rafael Blasco

Keyword(s):

Vaccinia Virus ◽

Structural Proteins ◽

Single Cycle ◽

Virus Recombinant ◽

Vaccinia Virus Recombinant

Download Full-text

Mucosal Administration of Completely Non-Replicative Vaccinia Virus Recombinant Dairen I strain Elicits Effective Mucosal and Systemic Immunity

Scandinavian Journal of Immunology ◽

10.1111/j.1365-3083.2008.02168.x ◽

2008 ◽

Vol 68 (5) ◽

pp. 476-483 ◽

Cited By ~ 2

Author(s):

N. Yoshino ◽

M. Kanekiyo ◽

Y. Hagiwara ◽

T. Okamura ◽

K. Someya ◽

...

Keyword(s):

Vaccinia Virus ◽

Systemic Immunity ◽

Virus Recombinant ◽

Vaccinia Virus Recombinant

Download Full-text

Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guerin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity

Journal of Virology ◽

10.1128/jvi.01681-06 ◽

2006 ◽

Vol 80 (20) ◽

pp. 10288-10288 ◽

Cited By ~ 2

Author(s):

Y. Ami ◽

Y. Izumi ◽

K. Matsuo ◽

K. Someya ◽

M. Kanekiyo ◽

...

Keyword(s):

Vaccinia Virus ◽

Mycobacterium Bovis ◽

Bacillus Calmette Guerin ◽

Virus Recombinant ◽

Vaccinia Virus Recombinant

Download Full-text

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

Archives of Virology ◽

10.1007/s00705-005-0676-9 ◽

2005 ◽

Vol 151 (5) ◽

pp. 921-931 ◽

Cited By ~ 32

Author(s):

A. D. Altstein ◽

A. K. Gitelman ◽

Y. A. Smirnov ◽

L. M. Piskareva ◽

L. G. Zakharova ◽

...

Keyword(s):

Avian Influenza ◽

Vaccinia Virus ◽

Experimental Infection ◽

Influenza A ◽

Influenza Viruses ◽

Avian Influenza Viruses ◽

Virus Recombinant ◽

Vaccinia Virus Recombinant

Download Full-text

Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation

Journal of Medical Virology ◽

10.1002/jmv.20349 ◽

2005 ◽

Vol 76 (2) ◽

pp. 248-255 ◽

Cited By ~ 20

Author(s):

Patricia Sastre ◽

José A. Melero ◽

Blanca García-Barreno ◽

Concepción Palomo

Keyword(s):

Respiratory Syncytial Virus ◽

Affinity Chromatography ◽

Vaccinia Virus ◽

Human Immunoglobulin ◽

Immunoglobulin Preparation ◽

Virus Recombinant ◽

Infected Cells ◽

Syncytial Virus ◽

Vaccinia Virus Recombinant

Download Full-text

MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis

Parasitology ◽

10.1017/s0031182003004761 ◽

2004 ◽

Vol 128 (4) ◽

pp. 397-405 ◽

Cited By ~ 21

Author(s):

J. L. ROQUE-RESNDIZ ◽

R. ROSALES ◽

P. HERION

Keyword(s):

Vaccinia Virus ◽

Vaccine Candidate ◽

Virus Recombinant ◽

Vaccinia Virus Recombinant

Download Full-text

Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice

Immunology Letters ◽

10.1016/j.imlet.2003.09.002 ◽

2003 ◽

Vol 90 (2-3) ◽

pp. 161-163 ◽

Cited By ~ 6

Author(s):

M.V Khoretonenko ◽

M.F Vorovitch ◽

L.G Zakharova ◽

G.V Pashvykina ◽

N.V Ovsyannikova ◽

...

Keyword(s):

Vaccinia Virus ◽

Encephalitis Virus ◽

Ns1 Protein ◽

Protective Activity ◽

Tick Borne Encephalitis ◽

Virus Recombinant ◽

Tick Borne Encephalitis Virus ◽

Vaccinia Virus Recombinant

Download Full-text

Vaccinia Virus Recombinant Expressing an 87-Kilodalton Polyprotein That Is Sufficient To Form Astrovirus-Like Particles

Journal of Virology ◽

10.1128/jvi.77.16.9094-9098.2003 ◽

2003 ◽

Vol 77 (16) ◽

pp. 9094-9098 ◽

Cited By ~ 19

Author(s):

Rosa M. Dalton ◽

Esperanza P. Pastrana ◽

Alicia Sánchez-Fauquier

Keyword(s):

Vaccinia Virus ◽

Acute Gastroenteritis ◽

Genomic Rna ◽

Virus Like Particles ◽

Virus Recombinant ◽

Human Astrovirus ◽

First Time ◽

Vaccinia Virus Recombinant

ABSTRACT Human astrovirus is an important cause of acute gastroenteritis. We have generated, for the first time, a vaccinia virus recombinant expressing the astrovirus 87-kDa structural polyprotein. The results demonstrate that this expression results in the formation of virus-like particles in the absence of other astrovirus proteins and genomic RNA. The purified trypsin-activated virus-like particles strongly resemble the complete astrovirus particles.

Download Full-text

The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK

Microbes and Infection ◽

10.1016/s1286-4579(02)00077-1 ◽

2003 ◽

Vol 5 (2) ◽

pp. 73-84 ◽

Cited By ~ 40

Author(s):

Esther Tapia ◽

Eva Pérez-Jiménez ◽

Laura López-Fuertes ◽

Rosa Gonzalo ◽

M.Magdalena Gherardi ◽

...

Keyword(s):

Immune Response ◽

Vaccinia Virus ◽

Cutaneous Leishmaniasis ◽

Protective Immune Response ◽

Virus Recombinant ◽

Dna Vectors ◽

Vaccinia Virus Recombinant

Download Full-text

vaccinia virus recombinant
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

NOVEL VACCINIA VIRUS RECOMBINANT FOR HUMAN SOLID TUMORS THERAPY – PRECLINICAL TRIALS RESULTS

A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles

Mucosal Administration of Completely Non-Replicative Vaccinia Virus Recombinant Dairen I strain Elicits Effective Mucosal and Systemic Immunity

Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guerin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation

MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis

Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice

Vaccinia Virus Recombinant Expressing an 87-Kilodalton Polyprotein That Is Sufficient To Form Astrovirus-Like Particles

The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK

Export Citation Format

vaccinia virus recombinantRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

NOVEL VACCINIA VIRUS RECOMBINANT FOR HUMAN SOLID TUMORS THERAPY – PRECLINICAL TRIALS RESULTS

A Vaccinia Virus Recombinant Transcribing an Alphavirus Replicon and Expressing Alphavirus Structural Proteins Leads to Packaging of Alphavirus Infectious Single Cycle Particles

Mucosal Administration of Completely Non-Replicative Vaccinia Virus Recombinant Dairen I strain Elicits Effective Mucosal and Systemic Immunity

Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guerin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation

MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis

Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice

Vaccinia Virus Recombinant Expressing an 87-Kilodalton Polyprotein That Is Sufficient To Form Astrovirus-Like Particles

The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK

vaccinia virus recombinant
Recently Published Documents